Micropan Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.99 Cr
as on 24-12-2024
- Satisfied Charges ₹ 5.00 M
as on 24-12-2024
- Revenue 28.77%
(FY 2021)
- Profit -23.67%
(FY 2021)
- Ebitda 6.07%
(FY 2021)
- Net Worth 23.30%
(FY 2021)
- Total Assets 13.14%
(FY 2021)
About Micropan Pharmachem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.99 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Varsha Pande, Reshma Naik, and Anouksha Pande serve as directors at the Company.
- CIN/LLPIN
U24233MH2012PTC230870
- Company No.
230870
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Micropan Pharmachem Private Limited offer?
Micropan Pharmachem Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Pharmaceutical Services, Chemical Intermediates, Intermediate Chemicals.
Who are the key members and board of directors at Micropan Pharmachem?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anouksha Pande  | Director | 13-Sep-2019 | Current |
| Varsha Pande | Director | 10-May-2012 | Current |
| Reshma Naik | Director | 20-Oct-2020 | Current |
Financial Performance of Micropan Pharmachem.
Micropan Pharmachem Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 28.77% increase. The company also saw a substantial fall in profitability, with a 23.67% decrease in profit. The company's net worth Soared by an impressive increase of 23.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Micropan Pharmachem?
In 2021, Micropan Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Micropan Pharmaceuticals Private LimitedActive 20 years 10 daysVarsha Pande and Anouksha Pande are mutual person
Charges (Loans)
₹19.91 M
₹5.00 M
Charges Breakdown by Lending Institutions
- Others : 1.99 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Feb 2024 | Others | ₹4.00 M | Open |
| 28 Jun 2022 | Others | ₹4.62 M | Open |
| 18 Jun 2022 | Others | ₹2.05 M | Open |
| 18 Jun 2022 | Others | ₹2.15 M | Open |
| 17 Oct 2019 | Others | ₹3.00 M | Open |
How Many Employees Work at Micropan Pharmachem?
Unlock and access historical data on people associated with Micropan Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Micropan Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Micropan Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
